Market Exclusive

Analyst Activity – Leerink Swann Initiates Coverage On AxoGen (NASDAQ:AXGN) With a Outperform

Analyst Ratings For AxoGen (NASDAQ:AXGN)

Today, Leerink Swann initiated coverage on AxoGen (NASDAQ:AXGN) with a Outperform.

There are 6 buy ratings on the stock.

The current consensus rating on AxoGen (NASDAQ:AXGN) is Buy (Score: 3.00) with a consensus target price of $14.38 per share, a potential 4.80% downside.

Some recent analyst ratings include

Recent Insider Trading Activity For AxoGen (NASDAQ:AXGN)
AxoGen (NASDAQ:AXGN) has insider ownership of 9.33% and institutional ownership of 64.79%.

Recent Trading Activity for AxoGen (NASDAQ:AXGN)
Shares of AxoGen closed the previous trading session at 15.10 down -0.50 -3.21% with 359,817 shares trading hands.

Exit mobile version